The SHIELD Study-silicosis

Silicosis

The SHIELD Study-silicosis Silicosis Treatment, Action, Screening and Surveillance in Rwanda Trials The SHIELD Whole Lung Lavage Study Efficiency of Pirfenidone for the Reduction of Pulmonary Metabolic, Inflammatory and Fibrogenic Activity in Patients With Silicosis Due to Artificial Stone and Progressive Massive Fibrosis The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial Specialized Center of Research in Occupational and Immunologic Lung Disease Oscillation Mechanics of the Respiratory System in Never-smoking Patients With Silicosis Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis DNA-damage Pathways in Workers Exposed to Silica (Caesar Stone) Oxidative Stress Biomarkers to Monitor and Early Detect Health Impairment in Workers Exposed to Silica (Caesar Stone) Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention Comprehensive Risk Assessment of People With Silicosis: A Population-based Study